AKT1 and hepatocellular carcinoma: And increasing studies demonstrate that inactivation of AKT signaling pathway inhibits tumor growth and enhances the sensitivity of tumor cells to chemotherapy drugs such as cisplatin and temozolomide [29–31], suggesting that inhibition of AKT pathway may be a promising strategy for HCC treatment.